^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
TAK-007
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Takeda, UT MD Anderson Cancer Center
Drug class:
CD19 inhibitor
Related drugs:
